BioCentury

8:00 AM GMT, Jan 5, 2015
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Emerging Company Profile

Mimicking proteoglycans

Symic Biomedical Inc. is developing a library of synthetic mimics that function like natural proteoglycans but are easier to manufacture and aren't susceptible to enzymatic degradation, opening up previously untapped therapeutic space.

Proteoglycans, which are found in the extracellular matrix, are a class of complex macromolecules composed of a core protein onto which glycosaminoglycan side chains are attached. The exact role of the proteoglycan depends on its components and tissue location.

CEO Ken Horne said low expression

Read the full 799 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.